Heparin, platelet aggregation, neutrophils, and cardiopulmonary bypass.

[1]  E. Kobayashi,et al.  Platelet aggregation during cardiopulmonary bypass evaluated by a laser light-scattering method. , 1999, The Annals of thoracic surgery.

[2]  R. Heyderman,et al.  Investigation of platelet-neutrophil interactions in whole blood by flow cytometry. , 1997, Journal of immunological methods.

[3]  P. Hjemdahl,et al.  A sensitive flow cytometric assay for circulating platelet–leucocyte aggregates , 1997, British journal of haematology.

[4]  S. Bélisle,et al.  Hemorrhage and the use of blood products after adult cardiac operations: myths and realities. , 1996, The Annals of thoracic surgery.

[5]  H. Nygren,et al.  Exposure of blood to biomaterial surfaces liberates substances that activate polymorphonuclear granulocytes. , 1996, The Journal of laboratory and clinical medicine.

[6]  M. Fisher,et al.  Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans. , 1996, Circulation.

[7]  J. Loscalzo,et al.  Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. , 1995, The Annals of thoracic surgery.

[8]  M. Noble,et al.  Impaired platelet aggregation after cardiopulmonary bypass in man: enhancement of collagen-induced aggregation in whole blood and plasma by adrenaline ex vivo. , 1995, Clinical science.

[9]  V. Menys,et al.  Original article: the influence of aspirin on the proaggregatory action of adrenaline after cardiopulmonary bypass in man. , 1995, Platelets.

[10]  M. Noble,et al.  Macroaggregation of Platelets in Plasma, as Distinct from Microaggregation in Whole Blood (and Plasma), as Determined Using Optical Aggregometry and Platelet Counting respectively, is Specifically Impaired following Cardiopulmonary Bypass in Man , 1994, Thrombosis and Haemostasis.

[11]  B. Smith,et al.  Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass. , 1994, The Journal of thoracic and cardiovascular surgery.

[12]  A. Marcus,et al.  Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. , 1993, The Journal of clinical investigation.

[13]  B. Pasche,et al.  The platelet function defect of cardiopulmonary bypass. , 1993, Blood.

[14]  K. Schrör.  The basic pharmacology of ticlopidine and clopidogrel. , 1993, Platelets.

[15]  J. Mathew,et al.  Cardiopulmonary bypass induces leukocyte-platelet adhesion. , 1992, Blood.

[16]  D. Hoppensteadt,et al.  Some objective considerations for the neutralization of the anticoagulant actions of recombinant hirudin. , 1991, Haemostasis.

[17]  L. Harker,et al.  Bleeding complications associated with cardiopulmonary bypass. , 1990, Blood.

[18]  Z. M. Chen,et al.  Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents. , 1990, The American journal of physiology.

[19]  J. Mustard,et al.  Effect of the Concentration of Ca2+ in the Suspending Medium on the Responses of Human and Rabbit Platelets to Aggregating Agents , 1989, Thrombosis and Haemostasis.

[20]  T. Barrowcliffe,et al.  Heparin and Bleeding: An Association with Lipase Release , 1988, Thrombosis and Haemostasis.

[21]  S. Marklund,et al.  Heparin-induced release of extracellular superoxide dismutase to human blood plasma. , 1987, The Biochemical journal.

[22]  M. Frojmovic,et al.  DIFFERENTIAL INHIBITION OF THE PLATELET ACTIVATION SEQUENCE: SHAPE CHANGE, MICRO- AND MACRO- AGGREGATION, BY A STABLE PROSTACYCLIN ANALOGUE (IL0PR0ST) , 1987, Thrombosis and Haemostasis.

[23]  M. Etherington,et al.  Intra-Platelet Platelet Factor 4 (IP.PF4) and the Heparin-Mobilisable Pool of PF4 in Health and Atherosclerosis , 1984, Thrombosis and Haemostasis.